Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation

Abstract Although neural stem/progenitor cells derived from human induced pluripotent stem cells (hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of hiPSC-NS/PCs is a potential problem for clinical applications. Therefore, to understand the mechanisms of tumorige...

Full description

Bibliographic Details
Main Authors: Miho Isoda, Tsukasa Sanosaka, Ryo Tomooka, Yo Mabuchi, Munehisa Shinozaki, Tomoko Andoh-Noda, Satoe Banno, Noriko Mizota, Ryo Yamaguchi, Hideyuki Okano, Jun Kohyama
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-023-04995-9
_version_ 1797806604404391936
author Miho Isoda
Tsukasa Sanosaka
Ryo Tomooka
Yo Mabuchi
Munehisa Shinozaki
Tomoko Andoh-Noda
Satoe Banno
Noriko Mizota
Ryo Yamaguchi
Hideyuki Okano
Jun Kohyama
author_facet Miho Isoda
Tsukasa Sanosaka
Ryo Tomooka
Yo Mabuchi
Munehisa Shinozaki
Tomoko Andoh-Noda
Satoe Banno
Noriko Mizota
Ryo Yamaguchi
Hideyuki Okano
Jun Kohyama
author_sort Miho Isoda
collection DOAJ
description Abstract Although neural stem/progenitor cells derived from human induced pluripotent stem cells (hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of hiPSC-NS/PCs is a potential problem for clinical applications. Therefore, to understand the mechanisms of tumorigenicity in NS/PCs, we clarified the cell populations of NS/PCs. We established single cell-derived NS/PC clones (scNS/PCs) from hiPSC-NS/PCs that generated undesired grafts. Additionally, we performed bioassays on scNS/PCs, which classified cell types within parental hiPSC-NS/PCs. Interestingly, we found unique subsets of scNS/PCs, which exhibited the transcriptome signature of mesenchymal lineages. Furthermore, these scNS/PCs expressed both neural (PSA-NCAM) and mesenchymal (CD73 and CD105) markers, and had an osteogenic differentiation capacity. Notably, eliminating CD73+ CD105+ cells from among parental hiPSC-NS/PCs ensured the quality of hiPSC-NS/PCs. Taken together, the existence of unexpected cell populations among NS/PCs may explain their tumorigenicity leading to potential safety issues of hiPSC-NS/PCs for future regenerative medicine.
first_indexed 2024-03-13T06:09:47Z
format Article
id doaj.art-cfe8d14e05724bbf98a625f354acb147
institution Directory Open Access Journal
issn 2399-3642
language English
last_indexed 2024-03-13T06:09:47Z
publishDate 2023-06-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj.art-cfe8d14e05724bbf98a625f354acb1472023-06-11T11:22:51ZengNature PortfolioCommunications Biology2399-36422023-06-016111510.1038/s42003-023-04995-9Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantationMiho Isoda0Tsukasa Sanosaka1Ryo Tomooka2Yo Mabuchi3Munehisa Shinozaki4Tomoko Andoh-Noda5Satoe Banno6Noriko Mizota7Ryo Yamaguchi8Hideyuki Okano9Jun Kohyama10Department of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineDepartment of Physiology, Keio University School of MedicineAbstract Although neural stem/progenitor cells derived from human induced pluripotent stem cells (hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of hiPSC-NS/PCs is a potential problem for clinical applications. Therefore, to understand the mechanisms of tumorigenicity in NS/PCs, we clarified the cell populations of NS/PCs. We established single cell-derived NS/PC clones (scNS/PCs) from hiPSC-NS/PCs that generated undesired grafts. Additionally, we performed bioassays on scNS/PCs, which classified cell types within parental hiPSC-NS/PCs. Interestingly, we found unique subsets of scNS/PCs, which exhibited the transcriptome signature of mesenchymal lineages. Furthermore, these scNS/PCs expressed both neural (PSA-NCAM) and mesenchymal (CD73 and CD105) markers, and had an osteogenic differentiation capacity. Notably, eliminating CD73+ CD105+ cells from among parental hiPSC-NS/PCs ensured the quality of hiPSC-NS/PCs. Taken together, the existence of unexpected cell populations among NS/PCs may explain their tumorigenicity leading to potential safety issues of hiPSC-NS/PCs for future regenerative medicine.https://doi.org/10.1038/s42003-023-04995-9
spellingShingle Miho Isoda
Tsukasa Sanosaka
Ryo Tomooka
Yo Mabuchi
Munehisa Shinozaki
Tomoko Andoh-Noda
Satoe Banno
Noriko Mizota
Ryo Yamaguchi
Hideyuki Okano
Jun Kohyama
Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
Communications Biology
title Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
title_full Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
title_fullStr Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
title_full_unstemmed Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
title_short Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
title_sort mesenchymal properties of ipsc derived neural progenitors that generate undesired grafts after transplantation
url https://doi.org/10.1038/s42003-023-04995-9
work_keys_str_mv AT mihoisoda mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT tsukasasanosaka mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT ryotomooka mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT yomabuchi mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT munehisashinozaki mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT tomokoandohnoda mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT satoebanno mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT norikomizota mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT ryoyamaguchi mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT hideyukiokano mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation
AT junkohyama mesenchymalpropertiesofipscderivedneuralprogenitorsthatgenerateundesiredgraftsaftertransplantation